PriceTracker GLP-1

GLP-1 TV · Patient story · views checked Oct 2026

Novo Nordisk's Rybelsus (semaglutide) is a first oral GLP-1 treatment for type 2 diabetes mellitus

Patient storyDoses of Videos5,126 views8:28Sep 2019

Our summary

A patient shares their experience with Rybelsus. It has no captions we could read, so this is drawn from its title and description.

One person's experience, in their words. Not medical advice.

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Rybelsus and semaglutide
Who is speaking
Patient

Find more like it

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV